Search

FedEx supports relief efforts for cholera outbreak in Haiti

FedEx supports WMI

FedEx has responded quickly to the recent cholera outbreak in Haiti and the pending hurricane byassisting non-profit agencies with disaster relief deliveries to Port-au-Prince.

“A key to quick response is having long-term relationships with relief organisations, andleveraging our transport and logistics expertise to provide speedy and efficient relief,” thecompany said.

Last week, FedEx airlifted ten water purification systems, while twenty more systems are beingflown from Miami to Haiti for Water Missions International (WMI). In addition, the company providedin-kind transport for the required components within the US. Each of these portable water treatmentsystems can provide clean water for 5,000 people each day, potentially saving some 150,000 Haitiansfrom water-borne illnesses.

FedEx said it places a premium on working with organisations that have on-the-ground capacity tomanage their shipments. “WMI staff are in Haiti to install the systems and have them running in twohours or less. One WMI treatment system can provide safe water to a community not only during thiscrisis, but for 20 years or more at a cost of less than one penny per day, per person,” FedExadded.

Earlier this year, FedEx provided more than $1.8 million in-kind and cash support for theearthquake relief efforts in Haiti, including in-kind charter flights to support global reliefefforts from agencies including Red Cross, World Vision, Heart to Heart International, DirectRelief International, The Salvation Army and Water Missions International. Within one day of theearthquake, FedEx had committed $425,000 in cash to support Haiti relief efforts. Within sevendays, it transported more than 250 tonnes of relief supplies and within the first month more than500 tonnes of aid shipments.

Webinar on recent changes in European postal regulation - May 15th
DELIVER Europe Event - June 4-5, Amsterdam
Read exclusive articles reporting on recent Leaders in Logistics events

© 2025 CEP Research copyright all rights reserved.